Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia

Major depressive disorder (MDD) is primarily hinged on the presence of either low mood and/or anhedonia to previously pleasurable events for a minimum of 2 weeks. Other clinical features that characterize MDD include disturbances in sleep, appetite, concentration and thoughts. The combination of any...

Full description

Saved in:
Bibliographic Details
Main Authors: Badamasi, Ibrahim Mohammed, Lye, Munn Sann, Ibrahim, Normala, Stanslas, Johnson
Format: Article
Published: Springer Wien 2019
Online Access:http://psasir.upm.edu.my/id/eprint/79985/
https://link.springer.com/article/10.1007/s00702-019-02014-y
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.upm.eprints.79985
record_format eprints
spelling my.upm.eprints.799852023-05-02T01:52:13Z http://psasir.upm.edu.my/id/eprint/79985/ Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia Badamasi, Ibrahim Mohammed Lye, Munn Sann Ibrahim, Normala Stanslas, Johnson Major depressive disorder (MDD) is primarily hinged on the presence of either low mood and/or anhedonia to previously pleasurable events for a minimum of 2 weeks. Other clinical features that characterize MDD include disturbances in sleep, appetite, concentration and thoughts. The combination of any/both of the primary MDD symptoms as well as any four of the other clinical features has been referred to as MDD. The challenge for replicating gene association findings with phenotypes of MDD as well as its treatment outcome is putatively due to stratification of MDD patients. Likelihood for replication of gene association findings is hypothesized with specificity in symptoms profile (homogenous clusters of symptom/individual symptoms) evaluated. The current review elucidates the genetic factors that have been associated with insomnia symptom of MDD phenotype, insomnia symptom as a constellation of neuro-vegetative cluster of MDD symptom, insomnia symptom of MDD as an individual entity and insomnia feature of treatment outcome. Homozygous CC genotype of 3111T/C, GSK3B-AT/TT genotype of rs33458 and haplotype of TPH1 218A/C were associated with insomnia symptom of MDD. Insomnia symptom of MDD was not resolved in patients with the A/A genotype of HTR2A-rs6311 when treated with SSRI. Homozygous short (SS) genotype-HTTLPR, GG genotype of HTR2A-rs6311 and CC genotype of HTR2A-rs6313 were associated with AD treatment-induced insomnia, while val/met genotype of BDNF-rs6265 and the TT genotype of GSK-3beta-rs5443 reduced it. Dearth of association studies may remain the bane for the identification of robust genetic endophenotypes in line with findings for genotypes of HTR2A-rs6311. Springer Wien 2019 Article PeerReviewed Badamasi, Ibrahim Mohammed and Lye, Munn Sann and Ibrahim, Normala and Stanslas, Johnson (2019) Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia. Journal of Neural Transmission, 126 (6). pp. 711-722. ISSN 1435-1463 https://link.springer.com/article/10.1007/s00702-019-02014-y 10.1007/s00702-019-02014-y
institution Universiti Putra Malaysia
building UPM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Putra Malaysia
content_source UPM Institutional Repository
url_provider http://psasir.upm.edu.my/
description Major depressive disorder (MDD) is primarily hinged on the presence of either low mood and/or anhedonia to previously pleasurable events for a minimum of 2 weeks. Other clinical features that characterize MDD include disturbances in sleep, appetite, concentration and thoughts. The combination of any/both of the primary MDD symptoms as well as any four of the other clinical features has been referred to as MDD. The challenge for replicating gene association findings with phenotypes of MDD as well as its treatment outcome is putatively due to stratification of MDD patients. Likelihood for replication of gene association findings is hypothesized with specificity in symptoms profile (homogenous clusters of symptom/individual symptoms) evaluated. The current review elucidates the genetic factors that have been associated with insomnia symptom of MDD phenotype, insomnia symptom as a constellation of neuro-vegetative cluster of MDD symptom, insomnia symptom of MDD as an individual entity and insomnia feature of treatment outcome. Homozygous CC genotype of 3111T/C, GSK3B-AT/TT genotype of rs33458 and haplotype of TPH1 218A/C were associated with insomnia symptom of MDD. Insomnia symptom of MDD was not resolved in patients with the A/A genotype of HTR2A-rs6311 when treated with SSRI. Homozygous short (SS) genotype-HTTLPR, GG genotype of HTR2A-rs6311 and CC genotype of HTR2A-rs6313 were associated with AD treatment-induced insomnia, while val/met genotype of BDNF-rs6265 and the TT genotype of GSK-3beta-rs5443 reduced it. Dearth of association studies may remain the bane for the identification of robust genetic endophenotypes in line with findings for genotypes of HTR2A-rs6311.
format Article
author Badamasi, Ibrahim Mohammed
Lye, Munn Sann
Ibrahim, Normala
Stanslas, Johnson
spellingShingle Badamasi, Ibrahim Mohammed
Lye, Munn Sann
Ibrahim, Normala
Stanslas, Johnson
Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
author_facet Badamasi, Ibrahim Mohammed
Lye, Munn Sann
Ibrahim, Normala
Stanslas, Johnson
author_sort Badamasi, Ibrahim Mohammed
title Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
title_short Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
title_full Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
title_fullStr Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
title_full_unstemmed Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
title_sort genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
publisher Springer Wien
publishDate 2019
url http://psasir.upm.edu.my/id/eprint/79985/
https://link.springer.com/article/10.1007/s00702-019-02014-y
_version_ 1765298654608883712
score 13.18916